Onego Bio secured a €14 million Series A extension from the European Innovation Council (EIC) Accelerator Program and existing investors.
04 July 2024
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom